¹øÈ£ Á¦¸ñ ÀÛ¼ºÀÚ ¿Ã¸°³¯Â¥ ´Ù¿î Á¶È¸¼ö
À½¿ë¼ö¿¡ ´ëÇÑ Routing monitoring ¿ä±¸¿¡ ´ëÇÑ ´ëÀÀ ¹æÇâ ¸ð»ö °ü¸®ÀÚ 2008-09-22 19 30
25 [±³À°¾È³»]ÀǾàǰ¹ë¸®µ¥À̼DZ³À°°úÁ¤-RA(¸®½ºÅ©ºÐ¼®)/URS(»ç¿ëÀڿ䱸 ±Ô°Ý¼­)(06/23~24) °ü¸®ÀÚ 2008-06-13 0 90
24 [±³À°¾È³»]ÀǾàǰ¹ë¸®µ¥À̼ǹ®¼­È­-VMP(¹ë¸®µ¥ÀÌ¼Ç Á¾ÇÕ°èȹ¼­ ÀÛ¼º)(06/09~11) °ü¸®ÀÚ 2008-06-09 0 81
23 »õ·Î¿î ǰÁú½Ã½ºÅÛÀÇ ±¸Ãà - ICH Q10 °ü¸®ÀÚ 2008-05-22 40 48
22 Áß±¹ ÇìÆÄ¸° °øÀå¿¡ ´ëÇÑ Á¶»ç ¹× warning letter °ü¸®ÀÚ 2008-05-13 0 35
21 Merck warning letter °ü¸®ÀÚ 2008-05-02 11 34
20 KFDA "ǰ¸ñº° »çÀü GMP Á¦µµ ¿î¿µÁöħ °ü¸®ÀÚ 2008-04-28 10 22
19 »õGMPÇØ¼³¼­_Á¦4°³Á¤ °ü¸®ÀÚ 2008-04-28 23 60
18 ½Å¾à °øÁ¤ ¹ë¸®µ¥ÀÌ¼Ç ÀûÇÕ ÆÇÁ¤ '³ô¾Æ' °ü¸®ÀÚ 2008-02-22 0 25
17 »õGMP±ÔÁ¤_Q&A(Up-date) °ü¸®ÀÚ 2008-02-20 29 50
16 ÀǾàǰ µî »õ GMPÁ¦µµ ¼³¸íȸ(20080218)-3 °ü¸®ÀÚ 2008-02-20 10 26
15 ÀǾàǰ µî »õ GMPÁ¦µµ ¼³¸íȸ(20080218)-2 °ü¸®ÀÚ 2008-02-20 10 20
14 ÀǾàǰ µî »õ GMPÁ¦µµ ¼³¸íȸ(20080218)-1 °ü¸®ÀÚ 2008-02-20 14 35
13 º¹ÁöºÎ, ¿ÃÇØ ½Å¾à°³¹ß 510¾ï¿ø Áö¿ø °ü¸®ÀÚ 2008-02-11 0 37
12 ÇÑ-EU FTA ÁöÀûÀç»ê±Ç ÀڷẸȣ 5³âÇÕÀÇ °ü¸®ÀÚ 2008-02-11 0 29
11 °³Á¤ GMP ±âÁØ Áؼö öÀú ¿äû °ü¸®ÀÚ 2008-02-01 12 40
10 ÀǾàǰµî ¹ë¸®µ¥ÀÌ¼Ç ½Ç½Ã¿¡ °üÇÑ ±ÔÁ¤(½Ä¾àû°í½Ã Á¦2008-5È£, 20080116) °ü¸®ÀÚ 2008-01-17 16 65
9 ¾à»ç¹ý½ÃÇà±ÔÄ¢ÀüºÎ°³Á¤·É(º¸°Çº¹ÁöºÎ·ÉÁ¦434È£) °ü¸®ÀÚ 2008-01-17 12 64
8 ½Ã¼³±âÁطɽÃÇà±ÔÄ¢ÀüºÎ°³Á¤·É(º¸°Çº¹ÁöºÎ·ÉÁ¦433È£) °ü¸®ÀÚ 2008-01-17 18 72
7 GMP ±âÁØÀ» ±¹Á¦¼öÁØÀ¸·Î Àü¸é°³Á¤ ½ÃÇà¿¡ °ü·ÃÇÑ KFDA º¸µµÀÚ·á °ü¸®ÀÚ 2008-01-17 15 36
1 [2] 
À̸§ Á¦¸ñ ³»¿ë